Mylotarg Recall: Cancer Drug Pulled Due to Health Risks, Low Benefits
The cancer drug Mylotarg is being pulled from the U.S. market after the FDA determined that it was ineffective and endangered patients’ health.
June 22, 2010 By: Staff Writers
The cancer drug Mylotarg is being pulled from the U.S. market after the FDA determined that it was ineffective and endangered patients’ health.
A South Dakota man has filed one of the first gastroparesis lawsuits against Ozempic manufacturers, alleging that users have not been adequately warned about the risk of severe vomiting and long-term stomach side effects.
The U.S. Navy has received more than 129,000 Camp Lejeune water contamination claims, according to court records.
Reader testimonials highlight the severe tooth damage suffered by many Suboxone users as lawyers pursue product liability lawsuits against the manufacturers.